Pfizer-BioNTech Vaccine Arrives in China as Beijing Makes Available Imported Vaccines for First Time The first batch of German-made Pfizer-BioNTech COVID-19 vaccine arrived in mainland China on April 13 and was made available to Chinese people for vaccination with a fee. This is the first time that the Chinese regime allowed Chinese people to receive an imported COVID-19 vaccine. The importer, Fosun Pharma from Shanghai China, ordered 100 million doses of the effective German-made COVID-19 vaccine for the mainland in December 2020. It’s unclear how many doses are available in this first batch. The Chinese regime has approved five locally made vaccines for emergency use, and vaccinated people without charging a fee. At the same time, the regime ambitiously exports the vaccines to developing countries with its vaccine diplomacy agenda, such as forcing Taiwan’s allies to break away from supporting the island nation in exchange for vaccines.